Preglan-E2 Tablet

Preglan-E2 Tablet contains dinoprostone as its active ingredient, which is a synthetic prostaglandin used in obstetrics and gynecology. It acts by stimulating uterine contractions, thereby inducing labor or abortion, depending on the clinical indication.

Uses:

• Induction of Labor: Preglan-E2 Tablet is prescribed to ripen the cervix and induce labor in pregnant women who have reached full-term pregnancy but have not yet started labor spontaneously.
• Abortion: It may also be used to terminate pregnancies in the second trimester or for therapeutic abortions in cases of fetal demise or congenital abnormalities incompatible with life.

Side Effects:

While generally safe and effective, Preglan-E2 Tablet may cause some side effects, including:

• Uterine hyperstimulation
• Uterine rupture
• Nausea or vomiting
• Diarrhea
• Fever
• Chills
• Headache
• Hypotension

These side effects are usually transient and resolve once the medication is discontinued. However, uterine hyperstimulation and uterine rupture are serious adverse effects that require immediate medical attention.

Precautions:

• Preglan-E2 Tablet should only be administered by healthcare professionals experienced in obstetrical management in a hospital setting equipped to provide emergency care.
• It should not be used in women with a history of cesarean section or uterine surgery, or in cases of suspected fetal distress, placenta previa, or unexplained vaginal bleeding.
• Prior to administration, a thorough assessment of maternal and fetal conditions should be conducted to ensure the safety and appropriateness of using Preglan-E2 Tablet.
• Close monitoring of uterine contractions, fetal heart rate, and maternal vital signs is essential during and after administration of Preglan-E2 Tablet.

When Not to Use:

Preglan-E2 Tablet is contraindicated in women with a hypersensitivity to dinoprostone or any other component of the formulation. It should also not be used in cases where vaginal delivery is contraindicated, such as placenta previa with a history of cesarean section.

FAQ:

1. How is Preglan-E2 Tablet administered?
   • Preglan-E2 Tablet is usually administered vaginally, either as a single dose or in divided doses, as directed by a healthcare professional.
2. Can Preglan-E2 Tablet be used for self-administration at home?
   • No, Preglan-E2 Tablet should only be administered under the supervision of a qualified healthcare provider in a hospital setting.
3. What should I do if I experience uterine hyperstimulation or uterine rupture after taking Preglan-E2 Tablet?
   • Seek immediate medical attention if you experience any signs or symptoms of uterine hyperstimulation or uterine rupture, such as severe abdominal pain, persistent contractions, or abnormal fetal heart rate.
4. How long does it take for Preglan-E2 Tablet to induce labor?
   • The onset and duration of labor induction with Preglan-E2 Tablet may vary depending on individual factors such as cervical ripeness and gestational age.
5. Can Preglan-E2 Tablet be used during breastfeeding?
   • There is limited information available on the excretion of dinoprostone in human breast milk. Therefore, it is recommended to avoid breastfeeding while using Preglan-E2 Tablet.